Radiopharmaceutical developers are moving quickly to bring new diagnostic and therapeutic capacity online, and these facilities are unique in that they don’t operate like traditional pharma or biotech companies. GMP requirements still apply, but shielding, hot cells, airflow, utilities, and workflow in a radioactive environment change how these buildings need to be designed and built. Early decisions directly affect radiation protection, material flow, validation, and startup.
So, what does this mean for design and construction? It means the critical decisions happen early. Equipment layout, shielding, and workflow are worked through upfront with vendors, and that becomes the basis for structure, MEP systems, and cleanroom design. That’s where our process is different. And once equipment layout, shielding, and workflow are defined, we use that as the working baseline for the entire project.
Our team coordinates directly with equipment vendors, shielding designers, and trade partners to lock in hot cell placement, vault construction, access, and maintenance clearances early. That coordination drives structural framing, embeds, and penetrations, along with duct routing, pressure relationships, and utility distribution tied to the process. We also build the construction sequence around how the facility will be installed and brought online. Long-lead equipment, shielding materials, and critical systems are planned around procurement and installation requirements so field work can progress without redesign.